FindAPhD Weekly PhD Newsletter | JOIN NOW FindAPhD Weekly PhD Newsletter | JOIN NOW

Overcoming antimicrobial resistance to tetracycline antibiotics

   Division of Medical Sciences

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Prof C Schofield, Prof F Duarte  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Commercial partner: Ineos / Ineos Oxford `Institute for Antimicrobial Resistance (IOI), Oxford

Tetracycline type antibacterials are a mainstay of modern medicine and are also widely used in farming. However, their use is increasingly compromised by resistance, including by the Tet-X enzymes which are the mechanistically interesting flavin dependent monoxygenases. Whilst work with the beta-lactam antibiotics, such as the pencillins and cephalosporins, has shown the clinical utility of protecting them from enzyme mediated resistance by use of an inhibitor in a combination therapies (e.g. Augmentin = penicillin + clavulanic acid, a beta-lactamase inhibitor), this approach is largely unexplored for other antibacterial classes, such as tetracyclines, including new generation compounds such as tigecycline. The project will aim to address this by enabling the development of inhibitors of the Tet-X enzymes. The project will involve assay development, structural (including high-throughput and time resolved methods) and mechanistic studies, and inhibitor design / screening / synthesis, with the precise focus depending on the interests of the particular student.

Details on entry requirements and how to apply can be found here.

Apply using course: DPhil in Organic Chemistry

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

PhD saved successfully
View saved PhDs